Paricalcitol Versus Calcifediol for Treating Hyperparathyroidism in Kidney Transplant Recipients.

Kidney Int Rep · 2018 · PMC5762965 · PMID 29340322

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a slight trendno p-value reported

Despite a slight trend to more serious and nonserious adverse events with PAR therapy, all treatment-related adverse events were nonserious and generally mild; patients fully recovered after treatment withdrawal.

also in 4,078 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.